Paper · 8668342

S phase specific formation of the human Rad51 protein nuclear foci in lymphocytes.

Tashiro S and 5 others. Oncogene, 1996. Cited by 146 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. S phase specific formation of the human Rad51 protein nuclear foci in lymphocytes. Papers, record 8668342. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8668342

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: S phase specific formation of the human Rad51 protein nuclear foci in lymphocytes.; PubMed
Journal: Oncogene; PubMed
Year: 1996; PubMed
Publication types: Journal Article, Research Support, Non-U.S. Gov't; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/8668342/; PubMed
The journal: https://conductscience.org/library/journal-index/8711562; PubMed
Citations, by iCite: 146; iCite
Relative citation ratio, by iCite: 2.48; iCite
Revised in PubMed: 2006-11-15; PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename
1	Tashiro S	S
2	Kotomura N	N
3	Shinohara A	A
4	Tanaka K	K
5	Ueda K	K
6	Kamada N	N

Source PubMed

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
DNA-Binding Proteins	Major topic
Lymphocytes	Major topic
S Phase	Major topic
Cell Nucleus
DNA
Humans
Lymphocyte Activation
Phytohemagglutinins
Rad51 Recombinase
Stimulation, Chemical

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by62

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 146 citations.

PMID	Title	Journal	Year	In Papers	Source
40,649,791	Targeting Topoisomerase I and DNA with LCS1269 Drives Glioblastoma Cell Death Despite ATM/Chk1/BRCA1/RAD51 Signaling Pathway Activation.	Int J Mol Sci	2025	https://conductscience.org/library/papers/40649791	PubMed
35,148,356	Beta human papillomavirus 8 E6 allows colocalization of non-homologous end joining and homologous recombination repair factors.	PLoS Pathog	2022	https://conductscience.org/library/papers/35148356	PubMed
33,841,503	Telomeric Double Strand Breaks in G1 Human Cells Facilitate Formation of 5' C-Rich Overhangs and Recruitment of TERRA.	Front Genet	2021	https://conductscience.org/library/papers/33841503	PubMed
32,499,797	OsMFS1/OsHOP2 Complex Participates in Rice Male and Female Development.	Front Plant Sci	2020	https://conductscience.org/library/papers/32499797	PubMed
32,471,999	Homologous recombination DNA repair deficiency and PARP inhibition activity in primary triple negative breast cancer.	Nat Commun	2020	https://conductscience.org/library/papers/32471999	PubMed
30,550,547	Ex vivo assays to predict enhanced chemosensitization by hyperthermia in urothelial cancer of the bladder.	PLoS One	2018	https://conductscience.org/library/papers/30550547	PubMed
27,892,797	NEK8 regulates DNA damage-induced RAD51 foci formation and replication fork protection.	Cell Cycle	2017	https://conductscience.org/library/papers/27892797	PubMed
25,765,654	RAD54 family translocases counter genotoxic effects of RAD51 in human tumor cells.	Nucleic Acids Res	2015	https://conductscience.org/library/papers/25765654	PubMed
24,970,156	Homologous recombination as a replication fork escort: fork-protection and recovery.	Biomolecules	2012	https://conductscience.org/library/papers/24970156	PubMed
24,832,651	BRCA1 and Its Network of Interacting Partners.	Biology (Basel)	2013	https://conductscience.org/library/papers/24832651	PubMed

1 to 10 of 62

See all 62 cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Gene	NCBI Gene ID	Linked by	In Genes
RAD51	5,888	PubTator's text mining	https://conductscience.org/library/genes/5888

Source NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8668342

GET https://conductscience.org/api/papers/v1/8668342/cited_by?page=2

API reference For AI assistants